TomoTherapy jumps after being added to Piper Jaffray’s Alpha List
TomoTherapy Inc. (Nasdaq:TOMO) is up 16% after investment bank Piper Jaffray added the Madison, Wis.-based maker of radiation therapy systems to its “Alpha List,” a list of companies whose shares Piper believes will move higher in the coming months. Piper reiterated its “buy” rating and $14 price target on TomoTherapy.
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
